Differentiating Factors Between Erythropoiesis-Stimulating AgentsA Guide to Selection for Anaemia of Chronic Kidney Disease

被引：0
|
作者：
Robert Deicher
Walter H. Hörl
机构：
[1] University of Vienna,Division of Nephrology and Dialysis, Department of Medicine III
[2] Universitätsklinik für Innere Medizin III,Klinische Abteilung für Nephrologie und Dialyse
来源：
Drugs | 2004年 / 64卷
关键词：
Chronic Kidney Disease; Subcutaneous Administration; Peritoneal Dialysis Patient; Sialic Acid Residue; Erythropoiesis Stimulate Agent;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Endogenous erythropoietin (EPO) consists of a central polypeptide core covered by post-translationally linked carbohydrates. Three of the four currently available erythropoiesis stimulating agents (ESA) — epoetin-α, epoetin-β and epoetin-ω — are composed of an identical amino acid sequence, but glycosylation varies as a result of type- and host cell-specific differences in the production process.
引用
收藏
页码：499 / 509
页数：10
相关论文
共 50 条
  • [1] Differentiating factors between erythropoiesis-stimulating agents -: A guide to selection for anaemia of chronic kidney disease
    Deicher, R
    Hörl, WH
    DRUGS, 2004, 64 (05) : 499 - 509
  • [2] Differentiating Factors Between Erythropoiesis-Stimulating Agents: An Update to Selection for Anaemia of Chronic Kidney Disease
    Hoerl, Walter H.
    DRUGS, 2013, 73 (02) : 117 - 130
  • [3] Differentiating Factors Between Erythropoiesis-Stimulating Agents: An Update to Selection for Anaemia of Chronic Kidney Disease
    Walter H. Hörl
    Drugs, 2013, 73 : 117 - 130
  • [4] Erythropoiesis-stimulating agents for anaemia in chronic kidney disease: are they all the same?
    Mudge, David W.
    Webster, Angela C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (12):
  • [5] Erythropoiesis-stimulating agents: Treating the anaemia of chronic kidney disease - Foreword
    Carrera, Fernando
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 1 - 1
  • [6] Equipotent Doses of Erythropoiesis-Stimulating Agents in Outpatients with Anaemia Secondary to Chronic Kidney Disease
    Escudero-Vilaplana, Vicente
    Martinez-Nieto, Concepcion
    Manuel Lopez-Gomez, Juan
    Vega-Martinez, Almudena
    Sanjurjo-Saez, Maria
    LATIN AMERICAN JOURNAL OF PHARMACY, 2013, 32 (03): : 454 - 458
  • [7] Biosimilar Erythropoiesis-Stimulating Agents in Chronic Kidney Disease
    Shah, Hitesh H.
    Fishbane, Steven
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (04) : 267 - 271
  • [8] Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis
    Palmer, Suetonia C.
    Saglimbene, Valeria
    Mavridis, Dimitris
    Salanti, Georgia
    Craig, Jonathan C.
    Tonelli, Marcello
    Wiebe, Natasha
    Strippoli, Giovanni F. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (12):
  • [9] Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis
    Chung, Edmund Y. M.
    Palmer, Suetonia C.
    Saglimbene, Valeria M.
    Craig, Jonathan C.
    Tonelli, Marcello
    Strippoli, Giovanni F. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (02):
  • [10] Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis
    Vicente Escudero-Vilaplana
    Concepción Martínez-Nieto
    Juan Manuel López-Gómez
    Almudena Vega-Martínez
    José María Bellón-Cano
    María Sanjurjo-Sáez
    International Journal of Clinical Pharmacy, 2013, 35 : 463 - 468
12345